series-b
Stage
1
Investors
About
Starnatx develops liver-extrinsic targeted lipid nanoparticle (LNP) delivery systems to advance RNA-based innovative therapeutics, including in vivo cell therapies and vaccines.
Explore Starnatx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.